CO6160246A2 - Metodo de usar celulas troncales inactivadas mitoticamente para preparacion de tejido dañado - Google Patents
Metodo de usar celulas troncales inactivadas mitoticamente para preparacion de tejido dañadoInfo
- Publication number
- CO6160246A2 CO6160246A2 CO09015685A CO09015685A CO6160246A2 CO 6160246 A2 CO6160246 A2 CO 6160246A2 CO 09015685 A CO09015685 A CO 09015685A CO 09015685 A CO09015685 A CO 09015685A CO 6160246 A2 CO6160246 A2 CO 6160246A2
- Authority
- CO
- Colombia
- Prior art keywords
- stem cells
- tissue
- inactivated
- mitotically
- lethally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Un método para reparar tejido, que comprende: inactivar mitóticamente y/o letalmente células troncales; y trasplantar las células troncales inactivadas mitóticamente y/o letalmente inactivadas en el tejido. 2.- El método de la reivindicación 1 en donde las células troncales son células troncales pluripotentes. 3.- El método de la reivindicación 2 en donde las células troncales pluripotentes se aíslan de embriones, placenta, o líquido amniótico: o se generan de cualquier estirpe de células o tejido. 4.- El método de la reivindicación 1 en donde las células troncales se inactivan usando un método efectivo para inhibir la proliferación ilimitada de células troncales embrionarias. 5.- El método de la reivindicación 2 en donde las células troncales se inactivan con irradiación o mitomicina C, fototerapia, o cualquier agente que inhiba la proliferación celular. 6.- El método de la reivindicación 1 en donde el tejido que se está reparando se selecciona del grupo conformado por tejido cardiaco, tejido nervioso, tejido muscular, tejido pancreático, tejido epitelial, tejido hematopoyético, tejido hepático, o cualquier tejido u árgano en el cuerpo.7.- El método de la reivindicación 1 en donde las células troncales inactivadas mitóticamente y/o letalmente inactivadas no forman teratomas.8.- Un método de inactivar mitóticamente y/o letalmente células troncales, que comprende: proveer células troncales pluripotentes; e inactivar las células troncales pluripotentes con un método efectivo para inhibir la proliferación limitada de las células troncales pluripotentes y efectivo para inactivar células troncales adultas, tales como sangre del cordón umbilical, para impedir su crecimiento o persistencia en el receptor.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80786106P | 2006-07-20 | 2006-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6160246A2 true CO6160246A2 (es) | 2010-05-20 |
Family
ID=38957623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09015685A CO6160246A2 (es) | 2006-07-20 | 2009-02-18 | Metodo de usar celulas troncales inactivadas mitoticamente para preparacion de tejido dañado |
Country Status (11)
Country | Link |
---|---|
US (3) | US9017658B2 (es) |
EP (1) | EP2049655A4 (es) |
JP (1) | JP2009544362A (es) |
CN (1) | CN101490244A (es) |
AU (1) | AU2009200637A1 (es) |
BR (1) | BRPI0714455A8 (es) |
CA (1) | CA2659021A1 (es) |
CO (1) | CO6160246A2 (es) |
MX (1) | MX2009000741A (es) |
RU (1) | RU2009105890A (es) |
WO (1) | WO2008011524A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2659021A1 (en) * | 2006-07-20 | 2008-01-24 | Richard Burt | Method of using mitotically inactivated stem cells for damaged tissue repair |
JP6243839B2 (ja) | 2011-06-29 | 2017-12-06 | バイオリストーラティブ セラピーズ, インコーポレイテッド | 褐色脂肪細胞の組成物および方法 |
US9364425B2 (en) * | 2012-03-19 | 2016-06-14 | Richard Burt | Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells |
AU2014253920B2 (en) | 2013-04-19 | 2019-07-04 | Biorestorative Therapies, Inc. | Human brown adipose derived stem cells and uses |
US10813955B2 (en) | 2015-09-29 | 2020-10-27 | Genani Corporation | Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells |
US11590175B2 (en) | 2017-08-23 | 2023-02-28 | Merakris Therapeutics Llc | Compositions containing amniotic components and methods for preparation and use thereof |
DE102018202268A1 (de) * | 2018-02-14 | 2019-08-14 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Verfahren zur Erhöhung der Sicherheit von Gewebepräparaten (tissue engineered products) für die klinische Anwendung |
WO2023046709A1 (en) | 2021-09-23 | 2023-03-30 | Aarhus Universitet | Ready-to-use stem cell therapeutic |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
WO1994000484A1 (en) | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
WO1999027076A1 (en) * | 1997-11-25 | 1999-06-03 | Arc Genomic Research | Pluripotent embryonic stem cells and methods of obtaining them |
US20030161817A1 (en) | 2001-03-28 | 2003-08-28 | Young Henry E. | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
DE60321440D1 (de) | 2002-02-06 | 2008-07-17 | Stiftung Caesar | Aus zähnen gewonnene pluripotente embryonalähnliche stammzellen und verwendungen davon |
JP2006506987A (ja) * | 2002-06-28 | 2006-03-02 | エクサイト セラピーズ インコーポレーティッド | 自己免疫および臓器または造血幹細胞移植に関連する免疫学的欠損を有する患者における免疫レパートリー回復のための組成物および方法 |
CA2493871A1 (en) | 2002-07-16 | 2004-01-22 | Hadi Aslan | Methods of implanting mesenchymal stem cells for tissue repair and formation |
JP2007508018A (ja) | 2003-10-08 | 2007-04-05 | べト−ステム インコーポレイテッド | 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット |
US20070092494A1 (en) | 2005-10-26 | 2007-04-26 | Biomet Manufacturing Corp. | Composition for wound healing using lyophilized skin or skin-derived collagen |
US8871198B2 (en) | 2006-03-29 | 2014-10-28 | Stemnion, Inc. | Methods related to wound healing |
US20070292401A1 (en) | 2006-06-20 | 2007-12-20 | Harmon Alexander M | Soft tissue repair and regeneration using stem cell products |
CA2659021A1 (en) * | 2006-07-20 | 2008-01-24 | Richard Burt | Method of using mitotically inactivated stem cells for damaged tissue repair |
US20080241113A1 (en) | 2007-03-01 | 2008-10-02 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of endometrial/menstrual cells |
US20110020291A1 (en) | 2007-11-17 | 2011-01-27 | Debrabrata Banerjee | Use of stem cells for wound healing |
CN101449822A (zh) | 2007-12-05 | 2009-06-10 | 詹承镇 | 胚胎端粒酶食品 |
US20100040583A1 (en) | 2008-03-27 | 2010-02-18 | Vincent Falanga | Compositions and methods using stem cells in cutaneous wound healing |
-
2007
- 2007-07-19 CA CA002659021A patent/CA2659021A1/en not_active Abandoned
- 2007-07-19 EP EP07840442A patent/EP2049655A4/en not_active Withdrawn
- 2007-07-19 BR BRPI0714455A patent/BRPI0714455A8/pt not_active Application Discontinuation
- 2007-07-19 JP JP2009521005A patent/JP2009544362A/ja active Pending
- 2007-07-19 CN CNA2007800273628A patent/CN101490244A/zh active Pending
- 2007-07-19 RU RU2009105890/10A patent/RU2009105890A/ru not_active Application Discontinuation
- 2007-07-19 MX MX2009000741A patent/MX2009000741A/es unknown
- 2007-07-19 WO PCT/US2007/073904 patent/WO2008011524A2/en active Application Filing
-
2009
- 2009-01-15 US US12/354,522 patent/US9017658B2/en active Active
- 2009-02-18 CO CO09015685A patent/CO6160246A2/es unknown
- 2009-02-18 AU AU2009200637A patent/AU2009200637A1/en not_active Abandoned
-
2015
- 2015-04-27 US US14/697,281 patent/US9867855B2/en active Active
- 2015-10-05 US US14/875,363 patent/US20160022744A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9867855B2 (en) | 2018-01-16 |
US20150328265A1 (en) | 2015-11-19 |
US20160022744A1 (en) | 2016-01-28 |
EP2049655A4 (en) | 2010-04-21 |
WO2008011524A2 (en) | 2008-01-24 |
CA2659021A1 (en) | 2008-01-24 |
US9017658B2 (en) | 2015-04-28 |
BRPI0714455A8 (pt) | 2018-10-16 |
JP2009544362A (ja) | 2009-12-17 |
US20090214491A1 (en) | 2009-08-27 |
AU2009200637A1 (en) | 2009-03-12 |
EP2049655A2 (en) | 2009-04-22 |
MX2009000741A (es) | 2009-07-17 |
RU2009105890A (ru) | 2010-08-27 |
WO2008011524A3 (en) | 2008-12-24 |
BRPI0714455A2 (pt) | 2013-04-02 |
CN101490244A (zh) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6160246A2 (es) | Metodo de usar celulas troncales inactivadas mitoticamente para preparacion de tejido dañado | |
BR112021023571A2 (pt) | Enxerto de emplastro de células-tronco / progenitores em órgãos sólidos | |
EP3673732A3 (en) | Engineering of humanized car t-cells and platelets by genetic complementation | |
AR110962A1 (es) | Composiciones y métodos de tratamiento de hemoglobinopatías | |
BR112017021536A2 (pt) | composições e métodos para o condicionamento não mieloablativo | |
BRPI0514387A (pt) | isolamento, cultivo e usos de células-tronco/progenitoras | |
WO2007035843A3 (en) | Methods and compositions for organ and tissue functionality | |
ATE485065T1 (de) | Gewebekonstruktionsvorrichtungen zur reparatur und regeneration von gewebe | |
BRPI0506474A (pt) | sistema de tecido com células tronco não diferenciadas derivadas no limbus da córnea | |
EP4269566A3 (en) | Genetic markers for engraftment of human cardiac ventricular progenitor cells | |
MXPA02007137A (es) | Fuente de tejido hepatico. | |
NZ609731A (en) | Compositions of adult organ stem cells and uses thereof | |
MX2020002474A (es) | Metodo de injerto de celulas a partir de tejidos solidos. | |
BR112019002584A2 (pt) | método para a geração de células do tipo células formadoras de colônia do mesoderma e/ou endoteliais apresentando capacidade de formação de vasos sanguíneos in vivo | |
UY38321A (es) | Proceso de obtención de un sustituto dérmico a partir de membrana amniótica descelularizada y su uso como agente de regeneración | |
GB2441268A (en) | Engineered extracellular matrices control stem cell behavior | |
MX2020006321A (es) | Celulas estromales mesenquimales y metodos para obtener celulas estromales mesenquimales del cordon umbilical. | |
RU2012104553A (ru) | Клетки, производные от кардиальной ткани | |
George et al. | Comparison of the response of human embryonic stem cells and their differentiated progenies to oxidative stress | |
WO2023201270A3 (en) | Therapeutic applications of crispr type v systems | |
WO2007116408A3 (en) | Pluripotent stem cells characterized by expression of germline specific genes | |
AR058796A1 (es) | Oligonucleotidos estimulantes de l a proliferacion de celulas madre mesenquimatosas y sus usos | |
Sheng et al. | Make room for dedifferentiation | |
MX2023005549A (es) | Celulas, tejidos, organos y animales que tienen uno o mas genes modificados para potenciar la supervivencia y tolerancia al xenoinjerto. | |
Yazdi et al. | Effect of 830 nm diode laser irradiation on human sperm motility |